Cargando…
Complement activation in COVID-19 and targeted therapeutic options: A scoping review
Increasing evidence suggests that activation of the complement system plays a key role in the pathogenesis and disease severity of Coronavirus disease 2019 (COVID-19). We used a systematic approach to create an overview of complement activation in COVID-19 based on histopathological, preclinical, mu...
Autores principales: | Lim, Endry Hartono Taslim, van Amstel, Rombout Benjamin Ezra, de Boer, Vieve Victoria, van Vught, Lonneke Alette, de Bruin, Sanne, Brouwer, Matthijs Christian, Vlaar, Alexander Petrus Johannes, van de Beek, Diederik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338830/ https://www.ncbi.nlm.nih.gov/pubmed/35934552 http://dx.doi.org/10.1016/j.blre.2022.100995 |
Ejemplares similares
-
Complement inhibition in severe COVID-19 – Blocking C5a seems to be key
por: Lim, Endry H.T., et al.
Publicado: (2021) -
Efficacy matters: broadening complement inhibition in COVID-19 – Authors' reply
por: Vlaar, Alexander P J, et al.
Publicado: (2021) -
Anti-C5a antibody vilobelimab treatment and the effect on biomarkers of inflammation and coagulation in patients with severe COVID-19: a substudy of the phase 2 PANAMO trial
por: Lim, Endry H. T., et al.
Publicado: (2022) -
Inhibiting C5 in patients with severe COVID-19—the incorrect target?
por: Lim, Endry H T, et al.
Publicado: (2023) -
Targeting the complement system in bacterial meningitis
por: Koelman, Diederik L H, et al.
Publicado: (2019)